NDC 53270-0126

VARIZIG

Varicella Zoster Immune Globulin (human)

VARIZIG is a Intramuscular Liquid in the Plasma Derivative category. It is labeled and distributed by Cangene Biopharma. The primary component is Human Varicella-zoster Immune Globulin.

• Product ID: 53270-0126_4794cffc-7356-409b-bd30-3b97531b2cf1
• NDC: 53270-0126
• Product Type: Plasma Derivative
• Proprietary Name: VARIZIG
• Generic Name: Varicella Zoster Immune Globulin (human)
• Dosage Form: Liquid
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2015-05-22
• Marketing Category: BLA / BLA
• Application Number: BLA125430
• Labeler Name: Cangene BioPharma
• Substance Name: HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN
• Active Ingredient Strength: 1 [iU]/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 53270-0126-2

1 VIAL in 1 CARTON (53270-0126-2) > 1 mL in 1 VIAL (53270-0126-1)

• Marketing Start Date: 2015-05-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 53270-0126-1 [53270012601]

VARIZIG LIQUID

• Marketing Category: BLA
• Application Number: BLA125430
• Product Type: PLASMA DERIVATIVE
• Billing Unit: ML
• Marketing Start Date: 2015-05-22

NDC 53270-0126-2 [53270012602]

VARIZIG LIQUID

• Marketing Category: BLA
• Application Number: BLA125430
• Product Type: PLASMA DERIVATIVE
• Billing Unit: ML
• Marketing Start Date: 2015-08-06

Drug Details

Active Ingredients

Ingredient	Strength
HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN	1.25 [iU]/mL

NDC Crossover Matching brand name "VARIZIG" or generic name "Varicella Zoster Immune Globulin (human)"

NDC	Brand Name	Generic Name
53270-0126	VARIZIG	Varicella Zoster Immune Globulin (Human)
70257-126	VariZig	Varicella Zoster Immune Globulin (Human)
70504-0126	VARIZIG	Varicella Zoster Immune Globulin (Human)